A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence.
Saved in:
| Title: | A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. |
|---|---|
| Authors: | Bivens E, Atiq O, Evans T, Bimali M, Brown G, Crane J, Darwish N, Faulkner JL, Govindarajan R, Johnson A, Kurilung A, Lazarenko O, Lu YW, Marsh K, Moreno M, Nookaew I, Robeson M, Sunde J, Ussery D, Vural E, Wilman M, Nakagawa M |
| Source: | Oncotarget [Oncotarget] 2026 Jun 05; Vol. 17 (1), pp. 291-305. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42249801 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bivens+E%22">Bivens E</searchLink><br /><searchLink fieldCode="AU" term="%22Atiq+O%22">Atiq O</searchLink><br /><searchLink fieldCode="AU" term="%22Evans+T%22">Evans T</searchLink><br /><searchLink fieldCode="AU" term="%22Bimali+M%22">Bimali M</searchLink><br /><searchLink fieldCode="AU" term="%22Brown+G%22">Brown G</searchLink><br /><searchLink fieldCode="AU" term="%22Crane+J%22">Crane J</searchLink><br /><searchLink fieldCode="AU" term="%22Darwish+N%22">Darwish N</searchLink><br /><searchLink fieldCode="AU" term="%22Faulkner+JL%22">Faulkner JL</searchLink><br /><searchLink fieldCode="AU" term="%22Govindarajan+R%22">Govindarajan R</searchLink><br /><searchLink fieldCode="AU" term="%22Johnson+A%22">Johnson A</searchLink><br /><searchLink fieldCode="AU" term="%22Kurilung+A%22">Kurilung A</searchLink><br /><searchLink fieldCode="AU" term="%22Lazarenko+O%22">Lazarenko O</searchLink><br /><searchLink fieldCode="AU" term="%22Lu+YW%22">Lu YW</searchLink><br /><searchLink fieldCode="AU" term="%22Marsh+K%22">Marsh K</searchLink><br /><searchLink fieldCode="AU" term="%22Moreno+M%22">Moreno M</searchLink><br /><searchLink fieldCode="AU" term="%22Nookaew+I%22">Nookaew I</searchLink><br /><searchLink fieldCode="AU" term="%22Robeson+M%22">Robeson M</searchLink><br /><searchLink fieldCode="AU" term="%22Sunde+J%22">Sunde J</searchLink><br /><searchLink fieldCode="AU" term="%22Ussery+D%22">Ussery D</searchLink><br /><searchLink fieldCode="AU" term="%22Vural+E%22">Vural E</searchLink><br /><searchLink fieldCode="AU" term="%22Wilman+M%22">Wilman M</searchLink><br /><searchLink fieldCode="AU" term="%22Nakagawa+M%22">Nakagawa M</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2026 Jun 05; Vol. 17 (1), pp. 291-305. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42249801 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.18632/oncotarget.28892 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 291 Titles: – TitleFull: A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bivens E – PersonEntity: Name: NameFull: Atiq O – PersonEntity: Name: NameFull: Evans T – PersonEntity: Name: NameFull: Bimali M – PersonEntity: Name: NameFull: Brown G – PersonEntity: Name: NameFull: Crane J – PersonEntity: Name: NameFull: Darwish N – PersonEntity: Name: NameFull: Faulkner JL – PersonEntity: Name: NameFull: Govindarajan R – PersonEntity: Name: NameFull: Johnson A – PersonEntity: Name: NameFull: Kurilung A – PersonEntity: Name: NameFull: Lazarenko O – PersonEntity: Name: NameFull: Lu YW – PersonEntity: Name: NameFull: Marsh K – PersonEntity: Name: NameFull: Moreno M – PersonEntity: Name: NameFull: Nookaew I – PersonEntity: Name: NameFull: Robeson M – PersonEntity: Name: NameFull: Sunde J – PersonEntity: Name: NameFull: Ussery D – PersonEntity: Name: NameFull: Vural E – PersonEntity: Name: NameFull: Wilman M – PersonEntity: Name: NameFull: Nakagawa M IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 06 Text: 2026 Jun 05 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1949-2553 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Oncotarget Type: main |
| ResultId | 1 |
